West-Ward Columbus

Hikma's Columbus facility, previously operating as West-Ward Columbus and Roxane Laboratories, is a cornerstone of the company's US generic pharmaceutical business. Located in Ohio, this site is one of the largest generic drug manufacturing facilities in the United States, specializing in complex dosage forms such as oral solids, liquids, and nasal sprays. The division focuses on a diverse portfolio of products across therapeutic areas including respiratory, oncology, and pain management. Following Hikma's acquisition of Roxane Laboratories in 2016, the site has integrated advanced R&D and large-scale production capabilities to support a robust pipeline of Abbreviated New Drug Applications (ANDAs). Today, the Columbus operations play a vital role in Hikma's mission to provide high-quality, affordable medicines to patients and healthcare providers nationwide.